Dan Shochat

Title: The Innovations of Dan Shochat

Introduction

Dan Shochat is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of radioprotection, particularly in the development of methods to enhance the stability of radiolabeled peptides. With a total of 2 patents, his work has implications for various applications in pharmaceuticals and medical research.

Latest Patents

Dan's latest patents focus on a radioprotectant for peptides labeled with radioisotopes. The first patent describes a method of ameliorating degradation of radiolabeled peptides, especially radiolabeled proteins such as antibodies. This method involves the inclusion of povidone, also known as polyvinylpyrrolidone or PVP, as a radioprotectant in a composition containing a radiolabeled peptide. Additionally, the patent outlines a stable peptide-radioisotope composition that incorporates povidone. Ascorbic acid or other secondary stabilizers may also be added to enhance radioprotection further. The second patent mirrors the first, emphasizing the same innovative approach to improving the stability of radiolabeled peptides.

Career Highlights

Dan Shochat is currently associated with Coulter Pharmaceutical, Inc., where he continues to advance his research in radioprotection. His work is pivotal in developing safer and more effective radiolabeled compounds for medical use.

Collaborations

Dan has collaborated with notable colleagues, including David Colcher and Michael J Buckley. Their combined expertise contributes to the innovative research and development efforts at Coulter Pharmaceutical.

Conclusion

Dan Shochat's contributions to the field of radioprotection through his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work not only enhances the stability of radiolabeled peptides but also paves the way for advancements in medical applications.